Describe how research and best-practices contribute to the implementation of EBM. Using a real or hypothetical healthcare organization, provide examples of when EBM may be successfully adopted in your organization or critique the organization for the lack of EBM being exhibited.

5.2 Evidence-Based Management Implementation

Describe how research and best-practices contribute to the implementation of EBM. Using a real or hypothetical healthcare organization, provide examples of when EBM may be successfully adopted in your organization or critique the organization for the lack of EBM being exhibited.

Would this article support or negate changes in your organization? Provide recommendations to support the application of this article as evidence or to refute it. If recommended, HOW will you potentially apply the information in this article to positively impact organizational goals or outcomes?

3.3 Appraisal of Evidence

Your EBM team is interested in the leadership style of managers and the impact the leadership style may have on the retention of staff. As such, your team determines an appropriate problem statement (hypothetical) to guide the literature inquiry and the following article is identified as relevant.

Critique this article in regard to its application to the desired outcomes of your EBM team, namely, the impact of leadership style on the retention of staff.

Would this article support or negate changes in your organization? Provide recommendations to support the application of this article as evidence or to refute it. If recommended, HOW will you potentially apply the information in this article to positively impact organizational goals or outcomes?

 

What is evidence based medicine (EBM)?Does the study have the potential to influence clinical practice?Was the participant blind to treatment allocation? Has there been adequate follow-up?

Critical appraisal of a trial

What is evidence based medicine (EBM)?Does the study have the potential to influence clinical
practice?

Was an appropriate method used to randomise the
participants?

Was the randomisation method clearly defined?

Sufficient separation between those who randomised and
those who administered the treatment?

Was the individual(s) administrating the treatment blind to
treatment allocation?

Was the participant blind to treatment allocation?
Has there been adequate follow-up?

Has the follow-up period been defined?

How were participants followed-up?

Is there a participant flow diagram outlining the number of
participants screened, recruited, randomised etc.?

Was an appropriate analysis method used? i.e. ITT or per
protocol

Within the scope of the statistical analysis plan, was the
data fully utilised?

How was missing data dealt with?

Are absolute measures considered alongside relative
measures of effect?

Have they presented a measure of uncertainty in the
treatment effect?

Adherence to treatment allocation been presented and
discussed?

What impact would a lack of adherence have on the
results?